glp 1 compounds PDB-101: Molecule of the Month: GLP-1 Receptor Agonists Compounded GLP-1s: Why doctors worry
Description
The first GLP-1 receptor agonist, exenatide, was developed in 2005 and safely prescribed ever since
Longitudinal analysis by Ong et al
In the STEP-1 trial published in the New England Journal of Medicine , approximately 3840% of total weight lost during semaglutide treatment came from lean mass rather than fat
What is the primary supply constraint facing anti-obesity drug producers
doi: 10.3945/ajcn.114.105833
Pflgers Archiv, 1998, 435(5): 583-594
